Aseptic spray drying offers a technology alternative to manufacture thermally stable vaccines.
Vaccine doses are often wasted due to challenges in maintaining cold storage from the manufacturing site to the patient. Aseptic spray drying offers a technology alternative to manufacture thermally stable vaccines, which can help ensure the stability and effectiveness of vaccines, extend shelf life, and reduce the potential for waste of these crucial products.
Read this article in Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing May 2021 eBook.
Sam de Costa is stabilization projects manager, Nova Laboratories Limited.
Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2021
May 2021
Pages: 18–24
When referring to this article, please cite it as S. de Costa, “Breaking the Cold Chain for Vaccines," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2021).
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.